---
figid: PMC5412470__ijms-18-00891-g007
figlink: /pmc/articles/PMC5412470/figure/ijms-18-00891-f007/
number: F7
caption: Model of direct or indirect protein-protein interaction of AmotL2, FKBP51,
  IQGAP2 and interacting partners. (PM) Plasma membrane. (NE) Nuclear envelope. AmotL2,
  as scaffold protein, may promote translocation and transcriptional activity of YAP.
  Upon YAP interaction with AmotL2, YAP shuttles between the cytoplasm and the nucleus.
  AmotL2 acts as a negative regulator of YAP by inducing its cytoplasmic retention
  or targeting it to cell junctions (1); Within the nucleus, YAP functions as a transcriptional
  coactivator of TEAD. The YAP-TEAD complex promotes the transcription of many genes
  that encode pro-proliferative and anti-apoptotic proteins. AmotL2 functions as a
  positive regulator of YAP by promoting its nuclear translocation (2), where AmotL2
  may act as a cofactor for the transcription of a group of YAP-TEAD target genes
  (2); Both ways of translocation of FKBP51 between mitochondrial and nuclear pool.
  In the nucleus, FKBP51 regulates, presumably blocking, transcription of GR-target
  genes, and possibly other targets (3); Cytosolic FKBP51 interacts with glucocorticoid
  hormone receptor (GR) and HSP90. Upon binding, the GR heterocomplex exchanges FKBP51
  for FKBP52. FKBP52-GR–chaperone complex is able to interact with dynein and walk
  by cytoskeletal tracts through cytosol and, through the nuclear pore, get into the
  nucleus, where dissociates and facilitates binding of the steroid-activated receptor
  to promoter sites (4); In its scaffolding function, IQGAP1 interacts with the MEK-ERK
  pathway hyperactivates ERK signaling and promotes tumor cell proliferation and survival
  (5). On the other hand, IQGAP1 interaction with the MEK-ERK pathway is dispensable
  in normal cell differentiation, growth, and survival []. IQGAP1 promotes cell division
  and proliferation through IQGAP1-TOR-Akt and suppresses differentiation and apoptosis
  driving to transformation [].
pmcid: PMC5412470
papertitle: Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal
  Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy.
reftext: Deborah Rotoli, et al. Int J Mol Sci. 2017 Apr;18(4):891.
pmc_ranked_result_index: '119561'
pathway_score: 0.9554096
filename: ijms-18-00891-g007.jpg
figtitle: Direct or indirect protein-protein interaction of AmotL2, FKBP51, IQGAP2
  and interacting partners
year: '2017'
organisms:
- Mus musculus
- Danio rerio
- Serinus canaria
- Homo sapiens
- Bos taurus
- Capra hircus
- Oryctolagus cuniculus
ndex: ddfab50c-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5412470__ijms-18-00891-g007.html
  '@type': Dataset
  description: Model of direct or indirect protein-protein interaction of AmotL2,
    FKBP51, IQGAP2 and interacting partners. (PM) Plasma membrane. (NE) Nuclear envelope.
    AmotL2, as scaffold protein, may promote translocation and transcriptional activity
    of YAP. Upon YAP interaction with AmotL2, YAP shuttles between the cytoplasm and
    the nucleus. AmotL2 acts as a negative regulator of YAP by inducing its cytoplasmic
    retention or targeting it to cell junctions (1); Within the nucleus, YAP functions
    as a transcriptional coactivator of TEAD. The YAP-TEAD complex promotes the transcription
    of many genes that encode pro-proliferative and anti-apoptotic proteins. AmotL2
    functions as a positive regulator of YAP by promoting its nuclear translocation
    (2), where AmotL2 may act as a cofactor for the transcription of a group of YAP-TEAD
    target genes (2); Both ways of translocation of FKBP51 between mitochondrial and
    nuclear pool. In the nucleus, FKBP51 regulates, presumably blocking, transcription
    of GR-target genes, and possibly other targets (3); Cytosolic FKBP51 interacts
    with glucocorticoid hormone receptor (GR) and HSP90. Upon binding, the GR heterocomplex
    exchanges FKBP51 for FKBP52. FKBP52-GR–chaperone complex is able to interact with
    dynein and walk by cytoskeletal tracts through cytosol and, through the nuclear
    pore, get into the nucleus, where dissociates and facilitates binding of the steroid-activated
    receptor to promoter sites (4); In its scaffolding function, IQGAP1 interacts
    with the MEK-ERK pathway hyperactivates ERK signaling and promotes tumor cell
    proliferation and survival (5). On the other hand, IQGAP1 interaction with the
    MEK-ERK pathway is dispensable in normal cell differentiation, growth, and survival
    []. IQGAP1 promotes cell division and proliferation through IQGAP1-TOR-Akt and
    suppresses differentiation and apoptosis driving to transformation [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FKBP5
  - TRAP1
  - FKBP4
  - FES
  - HSP90AB1
  - MAPK11
  - MAPK3
  - HSP90B1
  - MAPK13
  - MAPK9
  - MAPK1
  - MAP2K2
  - MAPK10
  - MAPK12
  - MAPK8
  - MAP2K1
  - AMOTL2
  - MAPK14
  - SRC
genes:
- word: FKBP51
  symbol: FKBP51
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP5
  entrez: '2289'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: FKBP52
  symbol: FKBP52
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP4
  entrez: '2288'
- word: FквPS
  symbol: FPS
  source: hgnc_alias_symbol
  hgnc_symbol: FES
  entrez: '2242'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MEK/ERK/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MEK/ERK/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK/ERK/MAPK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK/ERK/MAPK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AMOTL2
  symbol: AMOTL2
  source: hgnc_symbol
  hgnc_symbol: AMOTL2
  entrez: '51421'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK/ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
chemicals: []
diseases: []
figid_alias: PMC5412470__F7
redirect_from: /figures/PMC5412470__F7
figtype: Figure
---
